ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 120 filers reported holding ENZO BIOCHEM INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $127,000 | -89.4% | 15,674 | -86.3% | 0.01% | -89.0% |
| Q3 2017 | $1,201,000 | +1.2% | 114,790 | +6.7% | 0.08% | -5.7% |
| Q2 2017 | $1,187,000 | +246.1% | 107,576 | -7.6% | 0.09% | +262.5% |
| Q1 2015 | $343,000 | -41.3% | 116,370 | -11.6% | 0.02% | -38.5% |
| Q4 2014 | $584,000 | -19.2% | 131,646 | -6.2% | 0.04% | -17.0% |
| Q3 2014 | $723,000 | -25.9% | 140,413 | -24.5% | 0.05% | -27.7% |
| Q2 2014 | $976,000 | – | 186,003 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |